Zahra Nasehi

Zahra Nasehi

Auto-generated profile, based on publicly available information

Zahra Nasehi

Dept. of Clinical Biochemistry, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FJFaezeh Jozi
Faezeh Jozi
NKNejat Kheiripour
Nejat Kheiripour
MTMaryam Akhavan Taheri
Maryam Akhavan Taheri
AAAbolfazl Ardjmand
Abolfazl Ardjmand
GGGholamreza Ghavipanjeh
Gholamreza Ghavipanjeh
MSMohamad Esmaeil Esmaeil Shahaboddin
Mohamad Esmaeil Esmaeil Shahaboddin
Introduction. Diabetic nephropathy is one of the leading causes of end‐stage renal disease worldwide. Uncontrolled hyperglycemia and subsequent production of glycation end‐products activate the paths which lead to diabetic nephropathy. The aim of this study was to assess the effects of L‐lysine on antioxidant capacity, biochemical factors, kidney function, HSP70 level, and the expression of the TGFβ, VEGF, and RAGE genes in rats with streptozocin‐induced diabetes mellitus. Methods. Thirty‐two male Wistar rats were randomly allocated to four eight‐rat groups, namely, a healthy group, a diabetic group treated with vehicle (DM + vehicle), a diabetic group treated with L‐lysine (DM + Lys), and a healthy group treated with L‐lysine (healthy + Lys). Rats in the DM + Lys and the healthy + Lys groups were treated with L‐lysine 0.15%. The levels of fasting blood glucose, insulin, HbA1C, advanced glycation end‐products (AGEs), lipid profile, serum creatinine, blood urea nitrogen, glomerular filtration rate, urine microalbumin, oxidative stress parameters, kidney histology and morphology, and TGFβ, VEGF, and RAGE gene expressions were assessed. Findings. An eight‐week treatment with L‐lysine significantly reduced the levels of fasting blood glucose, AGEs, kidney function parameters, oxidative stress parameters, lipid profile, and the TGFβ, VEGF, and RAGE gene expression and significantly increased the levels of serum insulin and tissue HSP70. Conclusion. Treatment with L‐lysine seems to slow down the progression of diabetic nephropathy.

1 January 2023 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ZNZahra Nasehi
Zahra Nasehi
NKNejat Kheiripour
Nejat Kheiripour
MTMaryam Akhavan Taheri
Maryam Akhavan Taheri
AAAbolfazl Ardjmand
Abolfazl Ardjmand
FJFaezeh Jozi
Faezeh Jozi
MSMohamad Esmaeil Esmaeil Shahaboddin
Mohamad Esmaeil Esmaeil Shahaboddin
Introduction. Bile duct ligation (BDL) and subsequent cholestasis are associated with oxidative stress and liver injury and fibrosis. Hesperidin (3,5,7‐trihydroxyflavanone 7‐rhamnoglucoside) is a flavanone glycoside abundant in citrus fruits. It has positive effects on diabetic retinopathy, reduced platelet aggregation, and blood flow alterations and has the potential to reduce liver injury in oxidative stress. The aim of this study was to evaluate the hepatoprotective effects of hesperidin on BDL‐induced liver injury in rats. Methods. A total of 48 adult male Wistar rats were equally allocated to six eight‐rat groups, namely, a healthy group, a sham group, a BDL+Vehicle group (BDL plus treatment with distilled water), a BDL+VitC group (BDL plus treatment with vitamin C 4.25 μg/kg), a BDL+Hesp100 group (BDL plus treatment with hesperidin 100 mg/kg/day), and a BDL+Hesp200 group (BDL plus treatment with hesperidin 200 mg/kg/day). Treatments were orally provided for 21 consecutive days. Finally, rats were sacrificed through heart blood sampling. Blood samples were centrifuged, and liver function, oxidative stress, and antioxidant parameters were assessed. Liver tissue was also assessed for oxidative stress, antioxidant, and histological parameters. The expression of inflammatory genes, namely, TGFβ1, iNOS, Caspase‐3, and α‐SMA, was measured through polymerase chain reaction. Findings. Hesperidin supplementation was associated with significant decrease in the levels of liver enzymes, bilirubin, nitric oxide, malondialdehyde, protein carbonyl, and inflammatory gene expression; significant increase in the levels of total antioxidant capacity, glutathione, and superoxide dismutase and catalase enzyme activity; and significant improvement in the histological morphology and structure of the liver parenchyma. Conclusion. Hesperidin has significant positive effects on liver morphology and structure, inflammation, fibrosis, and oxidative stress in rats with BDL‐induced cholestatic liver injury.

1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ZNZahra Nasehi
Zahra Nasehi
NKNejat Kheiripour
Nejat Kheiripour
MTMaryam Akhavan Taheri
Maryam Akhavan Taheri
AAAbolfazl Ardjmand
Abolfazl Ardjmand
FJFaezeh Jozi
Faezeh Jozi
MSMohamad Esmaeil Esmaeil Shahaboddin
Mohamad Esmaeil Esmaeil Shahaboddin
This study is aimed at evaluating the effects of Securigera securidaca (SS) seed extract on cholestatic liver injury induced by bile duct ligation (BDL) in rats. Total polyphenols and flavonoids in SS seed extract were determined using a colorimetric assay, and their components were quantified using HPLC. Rats in four groups underwent BDL at the common bile duct and were treated for 21 days with either oral distilled water as vehicle, vitamin C, 100 mg/kg SS seed extract, or 200 mg/kg SS seed extract. Rats in the fifth group underwent abdominal incision without BDL and were treated with distilled water, and rats in the sixth group were healthy and received nothing. Finally, rats were sacrificed, blood samples were analyzed through biochemical methods, liver tissues were histologically assessed, and the expression of the TGFβ‐1, iNOS, caspase‐3, and α‐SMA genes in the liver was assessed through real‐time PCR. BDL significantly increased, and SS seed extract significantly decreased the serum levels of bilirubin and liver function enzymes. Moreover, SS seed extract suppressed the expression of the TGFβ‐1, iNOS, caspase‐3, and α‐SMA genes, reduced the levels of nitric oxide, malondialdehyde, and protein carbonyl, and increased the levels of glutathione, total antioxidant capacity, and SOD and catalase enzyme activity in the serum and liver. Extract at a dose of 100 mg/kg had significant positive effects on liver morphology and parenchyma structure in a dose‐dependent manner.

1 January 2026 in BioMed Research International
Verified
Journal Article
Open access
MAMehrasa Azizollahi
Mehrasa Azizollahi
MGMaedeh Ghasemi
Maedeh Ghasemi
ZNZahra Nasehi
Zahra Nasehi
MAMahdi Amani
Mahdi Amani
FZFouzieh Zadhoush
Fouzieh Zadhoush
Introduction: Chronic kidney disease (CKD) is a major global health concern, and evidence indicates that non‐alcoholic fatty liver disease (NAFLD) independently increases its risk and progression. This connection involves shared pathways such as chronic inflammation, oxidative stress, and insulin resistance, which can worsen renal injury. Caffeine (CAF) and naringin (NAR), with their antioxidant and anti‐inflammatory properties, may provide protective effects on both NAFLD and CKD. This study evaluated the impact of combined CAF and NAR treatment on insulin resistance and renal function in a high‐fat diet (HFD) induced NAFLD rat model. Materials and Methods: Thirty‐five male Wistar rats were randomly assigned to five groups (control, HFD, HFD + CAF, HFD + NAR, HFD + CAF + NAR; n = 7 per group). The HFD groups were fed a HFD (51% calories from fat) for 16 weeks, and from Week 10, received oral treatments with CAF (50 mg/kg/day), NAR (12.5 mg/kg/day), or their combination for 6 weeks. Key outcomes, including insulin resistance (HOMA‐IR), renal function (BUN, creatinine, and eGFR), and systemic inflammation (hs‐CRP) were evaluated at the study′s conclusion. Findings: HFD significantly increased glucose, HOMA‐IR, BUN, and hs‐CRP ( p < 0.0001), as well as insulin and creatinine levels ( p < 0.001), whereas eGFR decreased ( p < 0.01) compared with controls. Treatment with CAF or NAR partially improved these parameters. The combination therapy produced the most pronounced effects, significantly lowering HOMA‐IR and creatinine ( p < 0.0001), BUN and glucose ( p < 0.001), insulin (p <0.01), and hs‐CRP levels (p <0.05), while increasing eGFR ( p < 0.01). Conclusion: The CAF–NAR combination demonstrated superior effects compared with monotherapies in the NAFLD rat model, improving insulin resistance, enhancing renal function, and reducing systemic inflammation, thereby highlighting its potential as a promising approach for managing NAFLD‐related metabolic and renal complications.

1 January 2023 in Journal of Advances in Medical and Biomedical Research
Verified
Journal Article
Open access
PDF file
ZNZahra Nasehi
Zahra Nasehi
MSMohamad Esmaeil Esmaeil Shahaboddin
Mohamad Esmaeil Esmaeil Shahaboddin
SJSadegh Jafarnejad
Sadegh Jafarnejad
Background and Objective: It has been reported that allopathic drugs do not have significant effects on diabetes treatment. In contemporary literature, much attention has been given to the potential use of traditional medicines, including medicinal plants, in the treatment of metabolic abnormalities. Indeed, the effect of Securigera securidaca, as a medicinal agent, ...